Inventor

SNAPE MICHAEL FREDERICK

GB6 patents

⚠️ This page may combine multiple inventors who share the name “SNAPE MICHAEL FREDERICK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

NEUREN PHARMACEUTICALS LTD

4 patents

US9212204B2Dec 15, 2015

Treatment of rett syndrome using glycyl-L-2-methylprolyl-L-glutamic acid

NEUREN PHARMACEUTICALS LTD8 citations80

US9867823B2Jan 16, 2018

Neuroprotective bicyclic compounds and methods for their use in treating autism spectrum disorders and neurodevelopmental disorders

NEUREN PHARMACEUTICALS LTD3 citations67

US11197856B2Dec 14, 2021

Bicyclic compounds and methods for their use in treating autism

NEUREN PHARMACEUTICALS LTD0 citations55

US10548892B2Feb 4, 2020

Bicyclic compounds and methods for their use in treating autism spectrum disorders and neurodevelopmental disorders

NEUREN PHARMACEUTICALS LTD0 citations46

VERNALIS RES LTD

1 patent

US6828318B2Dec 7, 2004

2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission

VERNALIS RES LTD48 citations89

GLASS LARRY

1 patent

US9708366B2Jul 18, 2017

Treatment of fragile X syndrome using glycyl-L-2-methylprolyl-L-glutamate

GLASS LARRY7 citations78